Melatonin maintains adult hippocampal neurogenesis and cognitive functions after irradiation

Progress in Neurobiology

Volumn 90, Issue 1, 2010, Pages 60-68

  Manda, Kailash ^a   Reiter, Russel J ^b  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Adult neurogenesis; Cognitive dysfunction; Dentate gyrus; Melatonin; Radiation

Indexed keywords

AGOMELATINE; ALPHA TOCOPHEROL; ASCORBIC ACID; CURCUMIN; FREE RADICAL; MELATONIN; MITOCHONDRIAL DNA; PLACEBO; QUERCETIN; REACTIVE OXYGEN METABOLITE;

ABDOMINAL PAIN; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIOXIDANT ACTIVITY; BLOOD BRAIN BARRIER; BRAIN RADIATION; COGNITIVE DEFECT; DENTATE GYRUS; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BRAIN LEVEL; DRUG DIFFUSION; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG METABOLISM; DRUG PENETRATION; DRUG TISSUE LEVEL; HEADACHE; HUMAN; HUNTINGTON CHOREA; NAUSEA; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SOMNOLENCE; VIVID DREAM;

ANIMALS; ANTIOXIDANTS; BEHAVIOR; BEHAVIOR, ANIMAL; COGNITION; HIPPOCAMPUS; HUMANS; MELATONIN; NEUROGENESIS; NEURONS; NOOTROPIC AGENTS; RADIATION-PROTECTIVE AGENTS;

EID: 72049087712     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.10.019     Document Type: Review

References (149)

1. Abayomi O.K. Pathogenesis of irradiation-induced cognitive dysfunction. Acta Oncol. 35 (1996) 659-663
2. Abayomi O.K. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol. 41 (2002) 346-351
3. Armstrong K.J., and Niles L.P. Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells. Neuroreport 13 (2002) 473-475
4. Ascherio A., Rimm E.B., Hernán M.A., Giovannucci E., Kawachi I., Stampfer M.J., and Willett W.C. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann. Intern. Med. 130 (1999) 963-970
5. Banasr M., Soumier A., Hery M., Mocaer E., and Daszuta A. Agomelatine, a new antidepressant, induces regional changes in hippocampal neurogenesis. Biol. Psychiatry. 59 (2006) 1087-1096
6. Bao J.F., Wu R.G., Zhang X.P., Song Y., and Li C.L. Melatonin attenuates 1-methyl-4-phenylpyridinium-induced PC12 cell death. Acta Pharmacol. Sin. 26 (2005) 117-123
7. Barchas J., DaCosta F., and Spector S. Acute pharmacology of melatonin. Nature 214 (1967) 919-920
8. Becker D., and Sevilla M.D. The chemical consequences of radiation damage to DNA. Adv. Radiat. Biol. 17 (1993) 121-179
9. Benitez-King G., Huerto-Delgadillo L., and Anton-Tay F. Binding of 3H-melatonin to calmodulin. Life Sci. 53 (1993) 201-207
10. Benitez-King G., Hernandez M.E., Tovar R., and Ramirez G. Melatonin activates PKC-alpha but not PKC-epsilon in N1E-115 cells. Neurochem. Int. 39 (2001) 95-102
11. Benzi G., and Moretti A. Are reactive oxygen species involved in Alzheimer's disease?. Neurobiol. Aging 16 (1995) 661-674
12. Blickenstaff R.T., Brandstadter S.M., Reddy S., Witt R., and Lipkowitz K.B. Potential radioprotective agents. 2. Substituted anilines. J. Pharm. Sci. 83 (1994) 219-221
13. Cervantes M., Moralí G., and Letechipía-Vallejo G. Melatonin and ischemia-reperfusion injury of the brain. J. Pineal Res. 45 (2008) 1-7
14. Chen T.Y., Lee M.Y., Chen H.Y., Kuo Y.L., Lin S.C., Wu T.S., and Lee E.J. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J. Pineal Res. 40 (2006) 242-250
15. Chetsawang J., Govitrapong P., and Chetsawang B. Melatonin inhibits MPP+-induced caspase-mediated death pathway and DNA fragmentation factor-45 cleavage in SK-N-SH cultured cells. J. Pineal Res. 43 (2007) 115-120
16. Cheung R.T. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J. Pineal Res. 34 (2003) 153-160
17. Collier T.J., Quirk G.J., and Routtenberg A. Separable roles of hippocampal granule cells in forgetting and pyramidal cells in remembering spatial information. Brain Res. 409 (1987) 316-328
18. Coyle J.T., and Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262 (1993) 689-695
19. Crespy V., Morand C., Besson C., Cotelle N., Vezin H., Demigne C., and Remesy C. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am. J. Physiol. Gastrointest. Liver Physiol. 284 (2003) G980-988
20. Cuzzocrea S., and Reiter R.J. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur. J. Pharmacol. 426 (2001) 1-10
21. Dantas A.P., Tostes R.C., Fortes Z.B., Costa S.G., Nigro D., and Carvalho M.H. In vivo evidence for antioxidant potential of estrogen in microvessels of female spontaneously hypertensive rats. Hypertension 39 (2002) 405-411
22. Das A., Belagodu A., Reiter R.J., Ray S.K., and Banik N.L. Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J. Pineal Res. 45 (2008) 117-124
23. Dash P.K., Mach S.A., and Moore A.N. Enhanced neurogenesis in the rodent hippocampus following traumatic brain injury. J. Neurosci. Res. 63 (2001) 313-319
24. Dohi K., Satoh K., Nakamachi T., Yofu S., Hiratsuka K., Nakamura S., Ohtaki H., Yoshikawa T., Shioda S., and Aruga T. Does Edaravone (MCI-186) Act as an antioxidant and a neuroprotector in experimental traumatic brain injury?. Antioxid. Redox. Signal. 9 (2007) 281-287
25. Dubocovich M.L. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. 8 Suppl. 3 (2007) 34-42
26. Dubocovich M.L., Hudson R.L., Sumaya I.C., Masana M.I., and Manna E. Effect of MT1 melatonin receptor deletion on melatoninmediated phase shift of circadian rhythms in the C57BL/6 mouse. J. Pineal Res. 39 (2005) 113-120
27. Duthie G., and Crozier A. Plant-derived phenolic antioxidants. Curr. Opin. Clin. Nutr. Metab. Care 3 (2000) 447-451
28. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., and Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 4 (1998) 1313-1317
29. Feng Z., and Zhang J.T. Melatonin reduces amyloid beta-induced apoptosis in pheochromocytoma (PC12) cells. J. Pineal Res. 37 (2004) 257-266
30. Floyd R.A., and Carney J.M. Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress. Ann. Neurol. 32 (1992) S22-S27
31. Genovese T., Mazzon E., Crisafulli C., Esposito E., Di Paola R., Muia C., Di Bella P., Bramanti P., and Cuzzocrea S. Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J. Pineal Res. 43 (2007) 140-153
32. Gitto E., Pellegrino S., Gitto P., Barberi I., and Reiter R.J. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J. Pineal Res. 46 (2009) 128-139
33. Gould E., Beylin A., Tanapat P., Reeves A., and Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 2 (1999) 260-265
34. Graf B.A., Mullen W., Caldwell S.T., Hartley R.C., Duthie G.G., Lean M.E., Crozier A., and Edwards C.A. Disposition and metabolism of [2-14C]quercetin-4′-glucoside in rats. Drug Metab. Dispos. 33 (2005) 1036-1043
35. Guerrero J.M., and Reiter R.J. Melatonin-immune system relationships. Curr. Top. Med. Chem. 2 (2002) 167-179
36. Guzman-Marin R., Suntsova N., Methippara M., Greiffenstein R., Szymusiak R., and McGinty D. Sleep deprivation suppresses neurogenesis in the adult hippocampus of rats. Eur. J. Neurosci. 22 (2005) 2111-2116
37. Guzman-Marin R., Suntsova N., Bashir T., Nienhuis R., Szymusiak R., and McGinty D. Rapid eye movement sleep deprivation contributes to reduction of neurogenesis in the hippocampal dentate gyrus of the adult rat. Sleep 31 (2008) 167-175
38. Halliwell B. How to characterize a biological antioxidant. Free Rad. Res. Commun. 9 (1990) 1-32
39. Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006) 1634-1658
40. Halliwell B., Wasil M., and Grootvels M. Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorus acid by ascorbic acid. FEBS Lett. 213 (1987) 15-17
41. Halliwell B., and Aruoma O.I. DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Lett. 281 (1991) 9-19
42. Hardeland R. Melatonin, hormone of darkness and more-occurrence, control mechanisms, actions and bioactive metabolites. Cell. Mol. Life Sci. 65 (2008) 2001-2018
43. Hernandez-Rabaza V., Llorens-Martin M., Velazquez-Sanchez C., Ferragud A., Arcusa A., Gumus H.G., Gomez-Pinedo U., Perez-Villalba A., Rosello J., Trejo J.L., Barcia J.A., and Canales J.J. Inhibition of adult hippocampal neurogenesis disrupts contextual learning but spares spatial working memory, long-term conditional rule retention and spatial reversal. Neuroscience 159 (2009) 59-68
44. Holmes M.M., Galea L.A., Mistlberger R.E., and Kempermann G. Adult hippocampal neurogenesis and voluntary running activity: circadian and dose-dependent effects. J. Neurosci. Res. 76 (2004) 216-222
45. Ikushima T., Aritomi H., and Morisita J. Radioadaptive response: efficient repair of radiation-induced DNA damage in adapted cells. Mutat. Res. 358 (1996) 193-198
46. Jahnke G., Marr M., Myers C., Wilson R., Travlos G., and Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol. Sci. 50 (1999) 271-279
47. Jan J.E., Wasdell M.B., Freeman R.D., and Bax M. Evidence supporting the use of melatonin in short gestation infants. J. Pineal Res. 42 (2007) 22-27
48. Jou M.J., Peng T.I., Yu P.Z., Reiter R.J., Chen J.Y., Wu H.Y., Chen C.C., and Hsu L.F. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J. Pineal Res. 43 (2007) 389-403
49. Kalivendi S.V., Kotamraju S., Cunningham S., Shang T., Hillard C.J., and Kalyanaraman B. 1-Methyl-4-phenylpyridinium (MPP+)-induced apoptosis and mitochondrial oxidant generation: role of transferrin-receptor-dependent iron and hydrogen peroxide. Biochem. J. 371 (2003) 151-164
50. Karasek M., Reiter R.J., Cardinali D.P., and Pawlikowski M. Future of melatonin as a therapeutic agent. Neuro. Endocrinol. Lett. 23 Suppl. 1 (2002) 118-121
51. Kaya H., Delibas N., Serteser M., Ulukaya E., and Ozkaya O. The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther. Onkol. 175 (1999) 285-288
52. Kelloff G.J., Crowell J.A., Hawk E.T., Steele V.E., Lubet R.A., Boone C.W., Covey J.M., Doody L.A., Omenn G.S., Greenwald P., Hong W.K., Parkinson D.R., Bagheri D., Baxter G.T., Blunden M., Doeltz M.K., Eisenhauer K.M., Johnson K., Knapp G.G., Longfellow D.G., Malone W.F., Nayfield S.G., Seifried H.E., Swall L.M., and Sigman C.C. Strategy and planning for chemopreventive drug development: clinical development plans II. J. Cell Biochem. Suppl. 26 (1996) 54-71
53. Kempermann G. The neurogenic reserve hypothesis: what is adult hippocampal neurogenesis good for?. Trends Neurosci. 31 (2008) 163-169
54. Kilic E., Kilic U., Bacigaluppi M., Guo Z., Abdallah N.B., Wolfer D.P., Reiter R.J., Hermann D.M., and Bassetti C.L. Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J. Pineal Res. 45 (2008) 142-148
55. Kim J.S., Lee H.J., Kim J.C., Kang S.S., Bae C.S., Shin T., Jin J.K., Kim S.H., Wang H., and Moon C. Transient impairment of hippocampus-dependent learning and memory in relatively low-dose of acute radiation syndrome is associated with inhibition of hippocampal neurogenesis. J. Radiat. Res. (Tokyo) 49 (2008) 517-526
56. Kim M.J., Kim H.K., Kim B.S., and Yim S.V. Melatonin increases cell proliferation in the dentate gyrus of maternally separated rats. J. Pineal Res. 37 (2004) 193-197
57. Koh P.O. Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J. Pineal Res. 44 (2008) 101-106
58. Kong X., Li X., Cai Z., Yang N., Liu Y., Shu J., Pan L., and Zuo P. Melatonin regulates the viability and differentiation of rat midbrain neural stem cells. Cell. Mol. Neurobiol. 28 (2008) 569-579
59. Lane E.A., and Moss H.B. Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J. Clin. Endocrinol. Metab. 61 (1985) 1214-1216
60. Lee S.H., Chun W., Kong P.J., Han J.A., Cho B.P., Kwon O.Y., Lee H.J., and Kim S.S. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J. Pineal Res. 40 (2006) 79-85
61. Lee S.H., Oe T., and Blair I.A. Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292 (2001) 2083-2086
62. Limoli C.L., Giedzinski E., Rola R., Otsuka S., Palmer T.D., and Fike J.R. Radiation response of neural precursor cells: linking cellular sensitivity to cell cycle checkpoints, apoptosis and oxidative stress. Radiat. Res. 161 (2004) 17-27
63. Limoli C.L., Rola R., Giedzinski E., Mantha S., Huang T.T., and Fike J.R. Cell-density-dependent regulation of neural precursor cell function. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16052-16057
64. Limoli C.L., Giedzinski E., Baure J., Rola R., and Fike J.R. Altered growth and radiosensitivity in neural precursor cells subjected to oxidative stress. Int. J. Radiat. Biol. 82 (2006) 640-647
65. Limoli C.L., Giedzinski E., Baure J., Rola R., and Fike J.R. Redox changes induced in hippocampal precursor cells by heavy ion irradiation. Radiat. Environ. Biophys. 46 (2007) 167-172
66. Lin A.M., Fang S.F., Chao P.L., and Yang C.H. Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein. J. Pineal Res. 43 (2007) 163-171
67. Liu J., Solway K., Messing R.O., and Sharp F.R. Increased neurogenesis in the dentate gyrus after transient global ischemia in gerbils. J. Neurosci. 18 (1998) 7768-7778
68. Maharaj D.S., Walker R.B., Glass B.D., and Daya S. 6-Hydroxymelatonin protects against cyanide induced oxidative stress in rat brain homogenates. J. Chem. Neuroanat. 26 (2003) 1103-1107
69. Maldonado M.D., Murillo-Cabezas F., Terron M.P., Flores L.J., Tan D.X., Manchester L.C., and Reiter R.J. The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J. Pineal Res. 42 (2007) 1-11
70. Manach C., Scalbert A., Morand C., Remesy C., and Jimenez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 79 (2004) 727-747
71. Manda K., Anzai K., Kumari S., and Bhatia A.L. Melatonin attenuates radiation-induced learning deficit and brain oxidative stress in mice. Acta Neurobiol. Exp. (Wars) 67 (2007) 63-70
72. Manda K., Ueno M., Moritake T., and Anzai K. Radiation-induced cognitive dysfunction and cerebellar oxidative stress in mice: protective effect of alpha-lipoic acid. Behav. Brain Res. 177 (2007) 7-14
73. Manda K., Ueno M., and Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J. Pineal Res. 42 (2007) 386-393
74. Manda K., Ueno M., and Anzai K. Melatonin mitigates oxidative damage and apoptosis in mouse cerebellum induced by high-LET 56Fe particle irradiation. J. Pineal Res. 44 (2008) 189-196
75. Manda K., Ueno M., and Anzai K. Memory impairment, oxidative damage and apoptosis induced by space radiation: ameliorative potential of alpha-lipoic acid. Behav. Brain Res. 187 (2008) 387-395
76. Manda K., Ueno M., and Anzai K. Space radiation-induced inhibition of neurogenesis in the hippocampal dentate gyrus and memory impairment in mice: ameliorative potential of the melatonin metabolite, AFMK. J. Pineal Res. 45 (2008) 430-438
77. Manda K., Ueno M., and Anzai K. Cranial irradiation-induced inhibition of neurogenesis in hippocampal dentate gyrus of adult mice: attenuation by melatonin pretreatment. J. Pineal Res. 46 (2009) 71-78
78. Markakis E.A., and Gage F.H. Adult-generated neurons in the dentate gyrus send axonal projections to field CA3 and are surrounded by synaptic vesicles. J. Comp. Neurol. 406 (1999) 449-460
79. Marklund S.L., Westman N.G., Lundgren E., and Roos G. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res. 42 (1982) 1955-1961
80. Mates J.M., Perez-Gomez C., and Nunez de Castro I. Antioxidant enzymes and human diseases. Clin. Biochem. 32 (1999) 595-603
81. Mattiesen W.R., Tauber S.C., Gerber J., Bunkowski S., Brück W., and Nau R. Increased neurogenesis after hypoxic-ischemic encephalopathy in humans is age related. Acta Neuropathol. 117 (2009) 525-534
82. Menendez-Pelaez A., Poeggeler B., Reiter R.J., Barlow-Walden L., Pablos M.I., and Tan D.X. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell Biochem. 53 (1993) 373-382
83. Menendez-Pelaez A., and Reiter R.J. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J. Pineal Res. 15 (1993) 59-69
84. Millan M.J., Brocco M., Gobert A., and Dekeyne A. Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade. Psychopharmacology (Berl.) 177 (2005) 448-458
85. Mitchel R.E.J., and McCann R. Vitamin E is a complete tumor promotor in mouse skin. Carcinogenesis 14 (1993) 659-662
86. Mizumatsu S., Monje M.L., Morhardt D.R., Rola R., Palmer T.D., and Fike J.R. Extreme sensitivity of adult neurogenesis to low doses of X-irradiation. Cancer Res. 63 (2003) 4021-4027
87. Monje M.L., Mizumatsu S., Fike J.R., and Palmer T.D. Irradiation induces neural precursor-cell dysfunction. Nat. Med. 8 (2002) 955-962
88. Moriya T., Horie N., Mitome M., and Shinohara K. Melatonin influences the proliferative and differentiative activity of neural stem cells. J. Pineal Res. 42 (2007) 411-418
89. Mueller A.D., Pollock M.S., Lieblich S.E., Epp J.R., Galea L.A., and Mistlberger R.E. Sleep deprivation can inhibit adult hippocampal neurogenesis independent of adrenal stress hormones. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R1693-R1703
90. Matsubara E., Bryant-Thomas T., Pacheco, Quinto J., Henry T.L., Poeggeler B., Herbert D., Cruz-Sanchez F., Chyan Y.J., Smith M.A., Perry G., Shoji M., Abe K., Leone A., Grundke-Ikbal I., Wilson G.L., Ghiso J., Williams C., Refolo L.M., Pappolla M.A., Chain D.G., and Neria E. Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease. J. Neurochem. 85 (2003) 1101-1108
91. Matuszek Z., Bilska M.A., Reszka K.J., Chignell C.F., and Bilski P. Interaction of singlet molecular oxygen with melatonin and related indoles. Photochem. Photobiol. 78 (2003) 449-455
92. Niles L.P., Armstrong K.J., Rincon Castro L.M., Dao C.V., Sharma R., McMillan C.R., Doering L.C., and Kirkham D.L. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers. BMC Neurosci. 5 (2004) 41
93. Nitta Y., Kamiya K., Tanimoto M., Kagimoto O., Niwa O., and Yokoro K. Effects of administration of natural vitamin E on spontaneous hepatocarcinogenesis and N-dinitrosodiethylamine initiated tumors in mice. J. Toxicol. Pathol. 4 (1991) 55-61
94. Nitta Y., Kamiya K., Tanimoto M., Sadamoto S., Niwa O., and Yokoro K. Induction of transplantable tumors by repeated subcutaneous injections of natural and synthetic vitamin E in mice and rats. Jpn. J. Cancer Res. 82 (1991) 511-517
95. Noble M., Smith J., Power J., and Mayer-Proschel M. Redox state as a central modulator of precursor cell function. Ann. N. Y. Acad. Sci. 991 (2003) 251-271
96. Orrenius S., Gogvadze V., and Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 143-183
97. Overstreet D.H., Pucilowski O., Retton M.C., Delagrange P., and Guardiola-Lemaitre B. Effects of melatonin receptor ligands on swim test immobility. Neuroreport 9 (1998) 249-253
98. Panagiotakos G., Alshamy G., Chan B., Abrams R., Greenberg E., Saxena A., Bradbury M., Edgar M., Gutin P., and Tabar V. Long-term impact of radiation on the stem cell and oligodendrocyte precursors in the brain. PLoS ONE 2 (2007) e588
99. Papavasiliou P.S., Cotzias G.C., Duby S.E., Steck A.J., Bell M., and Lawrence W.H. Melatonin and parkinsonism. JAMA 221 (1972) 88-89
100. Papp M., Gruca P., Boyer P.A., and Mocaer E. Effect of agomelatine in the chronic mild stress model of depression in the rat. Neuropsychopharmacology 28 (2003) 694-703
101. Pappolla M.A., Sos M., Omar R.A., Bick R.J., Hickson-Bick D.L., Reiter R.J., Efthimiopoulos S., and Robakis N.K. Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide. J. Neurosci. 17 (1997) 1683-1690
102. Pappolla M.A., Chyan Y.J., Poeggeler B., Frangione B., Wilson G., Ghiso J., and Reiter R.J. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J. Neural. Transm. 107 (2000) 203-231
103. Parent J.M., Tada E., Fike J.R., and Lowenstein D.H. Inhibition of dentate granule cell neurogenesis with brain irradiation does not prevent seizure-induced mossy fiber synaptic reorganization in the rat. J. Neurosci. 19 (1999) 4508-4519
104. Peyrot F., and Ducrocq C. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species. J. Pineal Res. 45 (2008) 235-246
105. 2: protection by melatonin and related molecules. J. Pineal Res. 29 (2000) 54-61
106. Ramirez-Rodriguez G., Klempin F., Babu H., Benitez-King G., and Kempermann G. Melatonin modulates cell survival of new neurons in the hippocampus of adult mice. Neuropsychopharmacology 34 (2009) 2180-2191
107. Reiter R.J. Melatonin: the chemical expression of darkness. Mol. Cell Endocrinol. 79 (1991) C153-C158
108. Reiter R.J. Cytoprotective properties of melatonin: presumed association with oxidative damage and aging. Nutrition 14 (1998) 691-696
109. Reiter R.J. Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56 (1998) 359-384
110. Reiter R.J., Acuna-Castroviejo D., Tan D.X., and Burkhardt S. Free radical-mediated molecular damage. Mechanisms for the protective actions of melatonin in the central nervous system. Ann. N. Y. Acad. Sci. 939 (2001) 200-215
111. Reiter R.J., Tan D.X., Sainz R.M., Mayo J.C., and Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J. Pharm. Pharmacol. 54 (2002) 1299-1321
112. Reiter R.J., Tan D.X., Leon J., Kilic U., and Kilic E. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp. Biol. Med. 230 (2005) 104-117
113. Reiter R.J., Tan D.X., Manchester L.C., and Tamura H. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J. Physiol. Pharmacol. 58 Suppl. 6 (2007) 5-22
114. Reiter R.J., Tan D.X., Manchester L.C., Terron M.P., Flores L.J., and Koppisepi S. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv. Med. Sci. 52 (2007) 11-28
115. Reiter R.J., Sergio D., Paredes S.D., Korkmaz A., Jou M.J., and Tan D.X. Melatonin combats molecular terrorism at the mitochondrial level. Interdisc. Toxicol. 1 (2008) 137-149
116. 1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep. 8 (2003) 205-213
117. Rietjens I.M.C.M., Boersma M.G., Haan L., Spenkelink B., Awad H.M., Cnubben N.H.P., Zanden J.J.V., Woude H.V.D., Alink G.M., and Koeman J.H. The pro-oxidant chemistry of the natural antioxidants vitamin C, vitamin E, carotenoids and flavonoids. Environ. Toxicol. Pharmacol. 11 (2002) 321-333
118. Roman D.D., and Sperduto P.W. Neuropsychological effects of cranial radiation: current knowledge and future directions. Int. J. Radiat. Oncol. Biol. Phys. 31 (1995) 983-998
119. Sahay A., and Hen R. Adult hippocampal neurogenesis in depression. Nat. Neurosci. 10 (2007) 1110-1115
120. Sakano K., Oikawa S., Hiraku Y., and Kawanishi S. Oxidative DNA damage induced by a melatonin metabolite, 6-hydroxymelatonin, via a unique non-o-quinone type of redox cycle. Biochem. Pharmacol. 68 (2004) 1869-1878
121. Samantaray S., Sribnick E.A., Das A., Knaryan V.H., Matzelle D.D., Yallapragada A.V., Reiter R.J., Ray S.K., and Banik N.L. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J. Pineal Res. 44 (2008) 348-357
122. Samuni A., Aronovitch J., Godinger D., Chevion M., and Czapski G. On the cytotoxicity of vitamin C and metal ions. Eur. J. Biochem. 137 (1983) 119-124
123. Schaefer M., and Hardeland R. The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger. J. Pineal Res. 46 (2009) 49-52
124. Schapira A.H. Mitochondrial disorders. Biochim. Biophys. Acta 1410 (1999) 99-102
125. Seabra M.L., Bignotto M., Pinto Jr. L.R., and Tufik S. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J. Pineal Res. 29 (2000) 193-200
126. 2-formyl-5-methoxykynuramine. J. Pineal Res. 44 (2008) 450-455
127. 56Fe irradiation accelerates normal brain aging and produces deficits in spatial learning and memory. Adv. Space Res. 39 (2007) 1087-1092
128. Sies H. Biochemistry of oxidant stress. Angew. Chem. Int. Ed. Engl. 25 (1986) 1058-1071
129. Skinner D.C., and Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 140 (1999) 4399-4405
130. Sleeper E., Tamm C., Frisen J., Zhivotovsky B., Orrenius S., and Ceccatelli S. Cell death in adult neural stem cells. Cell. Death Differ. 9 (2002) 1377-1378
131. Snyder J.S., Kee N., and Wojtowicz J.M. Effects of adult neurogenesis on synaptic plasticity in the rat dentate gyrus. J. Neurophysiol. 85 (2001) 2423-2431
132. Soto-Vega E., Meza I., Ramirez-Rodriguez G., and Benitez-King G. Melatonin stimulates calmodulin phosphorylation by protein kinase C. J. Pineal Res. 37 (2004) 98-106
133. Tada E., Parent J.M., Lowenstein D.H., and Fike J.R. X-irradiation causes a prolonged reduction in cell proliferation in the dentate gyrus of adult rats. Neuroscience 99 (2000) 33-41
134. Tan D.X., Chen L.D., Poeggeler B., Manchester L.C., and Reiter R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1 (1993) 57-60
135. 2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15 (2001) 2294-2296
136. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., and Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J. Pineal Res. 42 (2007) 28-42
137. Temple N.J., and El-Khatib S.M. Cabbage and vitamin E: their effect on colon tumor formation in mice. Cancer Lett. 35 (1987) 71-77
138. Tengattini S., Reiter R.J., Tan D.X., Terron M.P., Rodella L.F., and Rezzani R. Cardiovascular diseases: protective effects of melatonin. J. Pineal Res. 44 (2008) 16-25
139. The alpha-tocopherol, beta carotene cancer prevention study group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330 (1994) 1029-1035
140. Then S.M., Mazlan M., Mat Top G., and Wan Ngah W.Z. Is Vitamin E toxic to neuron cells?. Cell Mol. Neurobiol. 29 (2009) 485-496
141. Tunez I., Montilla P., Del Carmen Munoz M., Feijoo M., and Salcedo M. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease. J. Pineal Res. 37 (2004) 252-256
142. van Praag H., Christie B.R., Sejnowski T.J., and Gage F.H. Running enhances neurogenesis, learning, and long-term potentiation in mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13427-13431
143. van Praag H., Schinder A.F., Christie B.R., Toni N., Palmer T.D., and Gage F.H. Functional neurogenesis in the adult hippocampus. Nature 415 (2002) 1030-1034
144. Vijayalaxmi, Meltz M.L., Reiter R.J., and Herman T.S. Melatonin and protection from genetic damage in blood and bone marrow: whole-body irradiation studies in mice. J. Pineal Res. 27 (1999) 221-225
145. Wallace S.S. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat. Res. 150 (1998) S60-79
146. Weishaupt J.H., Bartels C., Polking E., Dietrich J., Rohde G., Poeggeler B., Mertens N., Sperling S., Bohn M., Huther G., Schneider A., Bach A., Siren A.L., Hardeland R., Bahr M., Nave K.A., and Ehrenreich H. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J. Pineal Res. 41 (2006) 313-323
147. Yeleswaram K., McLaughlin L.G., Knipe J.O., and Schabdach D. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J. Pineal Res. 22 (1997) 45-51
148. Zaleska M.M., Nagy K., and Floyd R.A. Iron-induced lipid peroxidation and inhibition of dopamine synthesis in striatum synaptosomes. Neurochem. Res. 14 (1989) 597-605
149. 1-42. J. Pineal Res. 45 (2008) 157-165